Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1172

1.

Increasing rate of lymph node invasion in patients with prostate cancer treated with radical prostatectomy and lymph node dissection.

Preisser F, Nazzani S, Bandini M, Marchioni M, Tian Z, Montorsi F, Saad F, Briganti A, Steuber T, Budäus L, Huland H, Graefen M, Tilki D, Karakiewicz PI.

Urol Oncol. 2018 Jun 7. pii: S1078-1439(18)30171-6. doi: 10.1016/j.urolonc.2018.05.019. [Epub ahead of print]

PMID:
29887241
2.

Testicular microbiome in azoospermic men-first evidence of the impact of an altered microenvironment.

Alfano M, Ferrarese R, Locatelli I, Ventimiglia E, Ippolito S, Gallina P, Cesana D, Canducci F, Pagliardini L, Viganò P, Clementi M, Nebuloni M, Montorsi F, Salonia A.

Hum Reprod. 2018 May 30. doi: 10.1093/humrep/dey116. [Epub ahead of print]

PMID:
29850857
3.

Validation of the Social Security Administration Life Tables (2004-2014) in Localized Prostate Cancer Patients within the Surveillance, Epidemiology, and End Results database.

Preisser F, Bandini M, Mazzone E, Nazzani S, Marchioni M, Tian Z, Saad F, Pompe RS, Shariat SF, Heinzer H, Montorsi F, Huland H, Graefen M, Tilki D, Karakiewicz PI.

Eur Urol Focus. 2018 May 22. pii: S2405-4569(18)30123-8. doi: 10.1016/j.euf.2018.05.006. [Epub ahead of print]

PMID:
29802052
4.

Is imperative partial nephrectomy feasible for kidney cancer with venous thrombus involvement? Outcomes of 42 cases and matched pair analysis with a large radical nephrectomy cohort.

Marra G, Gontero P, Brattoli M, Filippini C, Capitanio U, Montorsi F, Daneshmand S, Huang WC, Linares Espinós E, Martínez-Salamanca JI, McKiernan JM, Zigeuner R, Libertino JA.

Urol Oncol. 2018 May 22. pii: S1078-1439(18)30129-7. doi: 10.1016/j.urolonc.2018.04.007. [Epub ahead of print]

PMID:
29801993
5.

Outcomes of Robot-assisted Partial Nephrectomy for Clinical T2 Renal Tumors: A Multicenter Analysis (ROSULA Collaborative Group).

Bertolo R, Autorino R, Simone G, Derweesh I, Garisto JD, Minervini A, Eun D, Perdona S, Porter J, Rha KH, Mottrie A, White WM, Schips L, Yang B, Jacobsohn K, Uzzo RG, Challacombe B, Ferro M, Sulek J, Capitanio U, Anele UA, Tuderti G, Costantini M, Ryan S, Bindayi A, Mari A, Carini M, Keehn A, Quarto G, Liao M, Chang K, Larcher A, De Naeyer G, De Cobelli O, Berardinelli F, Zhang C, Langenstroer P, Kutikov A, Chen D, De Luyk N, Sundaram CP, Montorsi F, Stein RJ, Haber GP, Hampton LJ, Dasgupta P, Gallucci M, Kaouk J, Porpiglia F.

Eur Urol. 2018 May 18. pii: S0302-2838(18)30351-8. doi: 10.1016/j.eururo.2018.05.004. [Epub ahead of print]

PMID:
29784191
6.

A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous Cohorts.

Ankerst DP, Straubinger J, Selig K, Guerrios L, De Hoedt A, Hernandez J, Liss MA, Leach RJ, Freedland SJ, Kattan MW, Nam R, Haese A, Montorsi F, Boorjian SA, Cooperberg MR, Poyet C, Vertosick E, Vickers AJ.

Eur Urol. 2018 May 16. pii: S0302-2838(18)30350-6. doi: 10.1016/j.eururo.2018.05.003. [Epub ahead of print]

PMID:
29778349
7.

How can we expand active surveillance criteria in patients with low- and intermediate-risk prostate cancer without increasing the risk of misclassification? Development of a novel risk calculator.

Gandaglia G, van den Bergh RCN, Tilki D, Fossati N, Ost P, Surcel CI, Sooriakumaran P, Tsaur I, Valerio M, Kretschmer A, Zaffuto E, Salomon L, Montorsi F, Graefen M, van der Poel H, de la Taille A, Briganti A, Ploussard G; European Association of Urology Young Academic Urologists Working Party on Prostate Cancer (EAU-YAUWP).

BJU Int. 2018 May 17. doi: 10.1111/bju.14391. [Epub ahead of print]

PMID:
29772103
8.

The Effect of Anatomical Location of Lymph Node Metastases on Cancer Specific Survival in Patients with Clear Cell Renal Cell Carcinoma.

Nini A, Larcher A, Cianflone F, Trevisani F, Terrone C, Volpe A, Regis F, Briganti A, Salonia A, Montorsi F, Bertini R, Capitanio U.

Front Surg. 2018 Mar 28;5:26. doi: 10.3389/fsurg.2018.00026. eCollection 2018.

9.

The effect of institution teaching status on perioperative outcomes after robotic partial or radical nephrectomy.

Marchioni M, Nazzani S, Preisser F, Bandini M, Tian Z, Kapoor A, Cindolo L, Primiceri G, Carmignani L, Briganti A, Montorsi F, Shariat SF, Schips L, Karakiewicz PI.

J Endourol. 2018 May 9. doi: 10.1089/end.2018.0025. [Epub ahead of print]

PMID:
29739253
10.

Impact of Adjuvant Radiotherapy in Node-positive Prostate Cancer Patients: The Importance of Patient Selection.

Abdollah F, Dalela D, Sood A, Keeley J, Alanee S, Briganti A, Montorsi F, Peabody JO, Menon M.

Eur Urol. 2018 Apr 30. pii: S0302-2838(18)30318-X. doi: 10.1016/j.eururo.2018.04.017. [Epub ahead of print]

PMID:
29720348
11.

Survival after radical prostatectomy or radiotherapy for locally advanced (cT3) prostate cancer.

Bandini M, Marchioni M, Preisser F, Zaffuto E, Tian Z, Tilki D, Montorsi F, Shariat SF, Saad F, Briganti A, Karakiewicz PI.

World J Urol. 2018 May 2. doi: 10.1007/s00345-018-2310-y. [Epub ahead of print]

PMID:
29717358
12.

Contemporary rates of adherence to international guidelines for pelvic lymph node dissection in radical cystectomy: a population-based study.

Zaffuto E, Bandini M, Gazdovich S, Valiquette AS, Leyh-Bannurah SR, Tian Z, Dell'Oglio P, Graefen M, Moschini M, Necchi A, Shariat SF, Briganti A, Montorsi F, Karakiewicz PI.

World J Urol. 2018 Apr 27. doi: 10.1007/s00345-018-2306-7. [Epub ahead of print]

PMID:
29704059
13.

Lymph node dissection during radical prostatectomy for prostate cancer: extending the template in the right patients without increasing complications.

Ventimiglia E, Briganti A, Montorsi F.

BJU Int. 2018 May;121(5):677-678. doi: 10.1111/bju.14169. No abstract available.

PMID:
29687951
14.

Preoperative Prediction of Node Metastases in Bladder Cancer Patients Using Genomic and Clinicopathologic Data.

Moschini M, Montorsi F.

EBioMedicine. 2018 May;31:5-6. doi: 10.1016/j.ebiom.2018.04.006. Epub 2018 Apr 7. No abstract available.

15.

Development and internal validation of a side-specific, multiparametric magnetic resonance imaging-based nomogram for the prediction of extracapsular extension of prostate cancer.

Martini A, Gupta A, Lewis SC, Cumarasamy S, Haines KG 3rd, Briganti A, Montorsi F, Tewari AK.

BJU Int. 2018 Apr 19. doi: 10.1111/bju.14353. [Epub ahead of print]

PMID:
29676063
16.

Anastomotic leaks and catheter time after salvage robot-assisted radical prostatectomy.

Bandini M, Gandaglia G, Fossati N, Montorsi F, Briganti A.

Transl Androl Urol. 2018 Mar;7(Suppl 1):S141-S143. doi: 10.21037/tau.2017.03.86. No abstract available.

17.

Evaluating the predictive accuracy and the clinical benefit of a nomogram aimed to predict survival in node-positive prostate cancer patients: External validation on a multi-institutional database.

Bianchi L, Schiavina R, Borghesi M, Bianchi FM, Briganti A, Carini M, Terrone C, Mottrie A, Gacci M, Gontero P, Imbimbo C, Marchioro G, Milanese G, Mirone V, Montorsi F, Morgia G, Novara G, Porreca A, Volpe A, Brunocilla E.

Int J Urol. 2018 Jun;25(6):574-581. doi: 10.1111/iju.13565. Epub 2018 Apr 6.

PMID:
29633372
18.

Will Image-guided Metastasis-directed Therapy Change the Treatment Paradigm of Oligorecurrent Prostate Cancer?

Giannarini G, Fossati N, Gandaglia G, Cucchiara V, Ficarra V, Mirone V, Montorsi F, Briganti A.

Eur Urol. 2018 Apr 3. pii: S0302-2838(18)30202-1. doi: 10.1016/j.eururo.2018.03.021. [Epub ahead of print] No abstract available.

PMID:
29625757
19.

Augmented reality during robot-assisted radical prostatectomy: expert robotic surgeons' on-the-spot insights after live surgery.

Porpiglia F, Bertolo R, Amparore D, Checcucci E, Artibani W, Dasgupta P, Montorsi F, Tewari A, Fiori C; ESUT.

Minerva Urol Nefrol. 2018 Apr;70(2):226-229. doi: 10.23736/S0393-2249.18.03143-0.

PMID:
29611674
20.

The role of neutrophil-to-lymphocyte ratio in men with erectile dysfunction-preliminary findings of a real-life cross-sectional study.

Ventimiglia E, Cazzaniga W, Pederzoli F, Frego N, Chierigo F, Capogrosso P, Boeri L, Dehò F, Abbate C, Moretti D, Piemonti L, Montorsi F, Salonia A.

Andrology. 2018 Apr 2. doi: 10.1111/andr.12489. [Epub ahead of print]

PMID:
29611369
21.

The effect of age on cancer specific mortality in patients with small renal masses: A population-based analysis.

Bandini M, Marchioni M, Pompe RS, Tian Z, Martel T, Chun FK, Cindolo L, Kapoor A, Montorsi F, Shariat SF, Briganti A, Karakiewicz PI.

Can Urol Assoc J. 2018 Mar 19. doi: 10.5489/cuaj.4854. [Epub ahead of print]

PMID:
29603918
22.

Treatment trends and Medicare reimbursements for localized prostate cancer in elderly patients.

Dell'oglio P, Valiquette AS, Leyh-Bannurah SR, Tian Z, Trudeau V, Larcher A, Shariat SF, Capitanio U, Briganti A, Graefen M, Montorsi F, Karakiewicz PI.

Can Urol Assoc J. 2018 Mar 19. doi: 10.5489/cuaj.4865. [Epub ahead of print]

PMID:
29603911
23.

Pattern of node metastases in patients treated with radical cystectomy and extended or superextended pelvic lymph node dissection due to bladder cancer.

Moschini M, Arbelaez E, Cornelius J, Mattei A, Shariat SF, Dell Oglio P, Zaffuto E, Salonia A, Montorsi F, Briganti A, Colombo R, Gallina A.

Urol Oncol. 2018 Jun;36(6):307.e9-307.e14. doi: 10.1016/j.urolonc.2018.03.002. Epub 2018 Mar 27.

PMID:
29602638
25.

Male infertility as a proxy of the overall male health status.

Capogrosso P, Ventimiglia E, Boeri L, Cazzaniga W, Chierigo F, Montorsi F, Salonia A.

Minerva Urol Nefrol. 2018 Mar 28. doi: 10.23736/S0393-2249.18.03063-1. [Epub ahead of print]

PMID:
29595040
26.

More Extensive Lymph Node Dissection at Radical Prostatectomy is Associated with Improved Outcomes with Salvage Radiotherapy for Rising Prostate-specific Antigen After Surgery: A Long-term, Multi-institutional Analysis.

Fossati N, Parker WP, Karnes RJ, Colicchia M, Bossi A, Seisen T, Di Muzio N, Cozzarini C, Noris Chiorda B, Fiorino C, Gandaglia G, Bartkowiak D, Wiegel T, Shariat S, Goldner G, Battaglia A, Joniau S, Haustermans K, De Meerleer G, Fonteyne V, Ost P, Van Poppel H, Montorsi F, Briganti A, Boorjian SA.

Eur Urol. 2018 Mar 12. pii: S0302-2838(18)30174-X. doi: 10.1016/j.eururo.2018.02.024. [Epub ahead of print]

PMID:
29544737
27.

The Impact of Implementation of the European Association of Urology Guidelines Panel Recommendations on Reporting and Grading Complications on Perioperative Outcomes after Robot-assisted Radical Prostatectomy.

Gandaglia G, Bravi CA, Dell'Oglio P, Mazzone E, Fossati N, Scuderi S, Robesti D, Barletta F, Grillo L, Maclennan S, N'Dow J, Montorsi F, Briganti A.

Eur Urol. 2018 Jul;74(1):4-7. doi: 10.1016/j.eururo.2018.02.025. Epub 2018 Mar 12.

PMID:
29544735
28.

Comparison of functional outcomes of robotic and open partial nephrectomy in patients with pre-existing chronic kidney disease: a multicenter study.

Hamilton ZA, Uzzo RG, Larcher A, Lane BR, Ristau B, Capitanio U, Ryan S, Dey S, Correa A, Reddy M, Proudfoot JA, Nasseri R, Yim K, Noyes S, Bindayi A, Montorsi F, Derweesh IH.

World J Urol. 2018 Mar 12. doi: 10.1007/s00345-018-2261-3. [Epub ahead of print]

PMID:
29532222
29.

Age at First Presentation for Erectile Dysfunction: Analysis of Changes over a 12-yr Period.

Capogrosso P, Ventimiglia E, Boeri L, Cazzaniga W, Chierigo F, Pederzoli F, Frego N, Abbate C, Dehò F, Montorsi F, Salonia A.

Eur Urol Focus. 2018 Mar 2. pii: S2405-4569(18)30068-3. doi: 10.1016/j.euf.2018.02.006. [Epub ahead of print]

PMID:
29506875
30.

Re: A Novel Tool for Predicting Extracapsular Extension During Graded Partial Nerve Sparing in Radical Prostatectomy.

Montironi R, Cheng L, Lopez-Beltran A, Scarpelli M, Montorsi F.

Eur Urol. 2018 Jun;73(6):978-980. doi: 10.1016/j.eururo.2018.01.033. Epub 2018 Feb 16. No abstract available.

PMID:
29458981
31.

Adjuvant Therapies in Nonmetastatic Renal-Cell Carcinoma: A Review of the Literature.

Bandini M, Smith A, Marchioni M, Pompe RS, Martel TF, Cindolo L, Montorsi F, Shariat SF, Briganti A, Kapoor A, Capitanio U, Karakiewicz PI.

Clin Genitourin Cancer. 2018 Jun;16(3):176-183. doi: 10.1016/j.clgc.2018.01.003. Epub 2018 Feb 2. Review.

PMID:
29449091
32.

External beam radiotherapy with or without androgen deprivation therapy in elderly patients with high metastatic risk prostate cancer.

Dell'Oglio P, Bandini M, Leyh-Bannurah SR, Tian Z, Trudeau V, Larcher A, Fossati N, Moschini M, Gandaglia G, Capitanio U, Briganti A, Graefen M, Montorsi F, Saad F, Karakiewicz PI.

Urol Oncol. 2018 May;36(5):239.e9-239.e15. doi: 10.1016/j.urolonc.2018.01.004. Epub 2018 Feb 14.

PMID:
29426698
33.

You Can Trust a Crystal Ball About as Far as You Can Throw It.

Capitanio U, Larcher A, Montorsi F, Karakiewicz P.

Eur Urol. 2018 May;73(5):781-782. doi: 10.1016/j.eururo.2018.01.019. No abstract available.

PMID:
29422370
34.

Comparison of Partial Versus Radical Nephrectomy Effect on Other-cause Mortality, Cancer-specific Mortality, and 30-day Mortality in Patients Older Than 75 Years.

Marchioni M, Preisser F, Bandini M, Nazzani S, Tian Z, Kapoor A, Cindolo L, Abdollah F, Tilki D, Briganti A, Montorsi F, Shariat SF, Schips L, Karakiewicz PI.

Eur Urol Focus. 2018 Feb 2. pii: S2405-4569(18)30008-7. doi: 10.1016/j.euf.2018.01.007. [Epub ahead of print]

PMID:
29398456
36.

Risk Based Surveillance after Surgical Treatment of Renal Cell Carcinoma.

Capogrosso P, Larcher A, Sjoberg DD, Vertosick EA, Cianflone F, Dell'Oglio P, Carenzi C, Salonia A, Vickers AJ, Montorsi F, Bertini R, Capitanio U.

J Urol. 2018 Jul;200(1):61-67. doi: 10.1016/j.juro.2018.01.072. Epub 2018 Jan 31.

PMID:
29371091
37.

Surgical treatment for clinical node-positive bladder cancer patients treated with radical cystectomy without neoadjuvant chemotherapy.

Moschini M, Mattei A, Cornelius J, Shariat SF, Dell'Oglio P, Zaffuto E, Salonia A, Montorsi F, Briganti A, Colombo R, Gallina A.

World J Urol. 2018 Apr;36(4):639-644. doi: 10.1007/s00345-018-2190-1. Epub 2018 Jan 24.

PMID:
29368231
38.

Contemporary Trends and Survival Outcomes After Aborted Radical Prostatectomy in Lymph Node Metastatic Prostate Cancer Patients.

Bandini M, Preisser F, Nazzani S, Marchioni M, Tian Z, Fossati N, Gandaglia G, Gallina A, Abdollah F, Shariat SF, Montorsi F, Saad F, Tilki D, Briganti A, Karakiewicz PI.

Eur Urol Focus. 2018 Jan 20. pii: S2405-4569(18)30010-5. doi: 10.1016/j.euf.2018.01.009. [Epub ahead of print]

PMID:
29366856
39.

Neoadjuvant and adjuvant treatment in high-risk prostate cancer.

Bandini M, Fossati N, Gandaglia G, Preisser F, Dell'Oglio P, Zaffuto E, Stabile A, Gallina A, Suardi N, Shariat SF, Montorsi F, Karakiewicz PI, Briganti A.

Expert Rev Clin Pharmacol. 2018 Apr;11(4):425-438. doi: 10.1080/17512433.2018.1429265. Epub 2018 Jan 25. Review.

PMID:
29355037
40.

The Impact of Lymph Node Metastases Burden at Radical Prostatectomy.

Preisser F, Marchioni M, Nazzani S, Bandini M, Tian Z, Pompe RS, Montorsi F, Saad F, Abdollah F, Steuber T, Heinzer H, Huland H, Graefen M, Tilki D, Karakiewicz PI.

Eur Urol Focus. 2018 Jan 3. pii: S2405-4569(17)30296-1. doi: 10.1016/j.euf.2017.12.009. [Epub ahead of print]

PMID:
29306731
41.

Preoperative multiparametric MRI of the prostate for the prediction of lymph node metastases in prostate cancer patients treated with extended pelvic lymph node dissection.

Brembilla G, Dell'Oglio P, Stabile A, Ambrosi A, Cristel G, Brunetti L, Damascelli A, Freschi M, Esposito A, Briganti A, Montorsi F, Del Maschio A, De Cobelli F.

Eur Radiol. 2018 May;28(5):1969-1976. doi: 10.1007/s00330-017-5229-6. Epub 2017 Dec 21.

PMID:
29270644
42.

History and evolution of the use of oral mucosa for urethral reconstruction.

Barbagli G, Balò S, Montorsi F, Sansalone S, Lazzeri M.

Asian J Urol. 2017 Apr;4(2):96-101. doi: 10.1016/j.ajur.2016.05.006. Epub 2016 Jun 26. Review.

43.

A Head-to-head Comparison of Four Prognostic Models for Prediction of Lymph Node Invasion in African American and Caucasian Individuals.

Bandini M, Marchioni M, Preisser F, Nazzani S, Tian Z, Fossati N, Gandaglia G, Shariat SF, Montorsi F, Saad F, Briganti A, Tilki D, Karakiewicz PI.

Eur Urol Focus. 2017 Dec 14. pii: S2405-4569(17)30269-9. doi: 10.1016/j.euf.2017.11.013. [Epub ahead of print]

PMID:
29249688
44.

Adherence to pelvic lymph node dissection recommendations according to the National Comprehensive Cancer Network pelvic lymph node dissection guideline and the D'Amico lymph node invasion risk stratification.

Leyh-Bannurah SR, Budäus L, Zaffuto E, Pompe RS, Bandini M, Briganti A, Montorsi F, Schiffmann J, Shariat SF, Fisch M, Chun F, Huland H, Graefen M, Karakiewicz PI.

Urol Oncol. 2018 Feb;36(2):81.e17-81.e24. doi: 10.1016/j.urolonc.2017.10.022. Epub 2017 Dec 14.

PMID:
29248430
45.

Anti-Mullerian Hormone-to-Testosterone Ratio is Predictive of Positive Sperm Retrieval in Men with Idiopathic Non-Obstructive Azoospermia.

Alfano M, Ventimiglia E, Locatelli I, Capogrosso P, Cazzaniga W, Pederzoli F, Frego N, Matloob R, Saccà A, Pagliardini L, Viganò P, Zerbi P, Nebuloni M, Pontillo M, Montorsi F, Salonia A.

Sci Rep. 2017 Dec 15;7(1):17638. doi: 10.1038/s41598-017-17420-z.

46.

Use of Concomitant Androgen Deprivation Therapy in Patients Treated with Early Salvage Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: Long-term Results from a Large, Multi-institutional Series.

Gandaglia G, Fossati N, Karnes RJ, Boorjian SA, Colicchia M, Bossi A, Seisen T, Cozzarini C, Di Muzio N, Noris Chiorda B, Zaffuto E, Wiegel T, Shariat SF, Goldner G, Joniau S, Battaglia A, Haustermans K, De Meerleer G, Fonteyne V, Ost P, Van Poppel H, Montorsi F, Briganti A.

Eur Urol. 2018 Apr;73(4):512-518. doi: 10.1016/j.eururo.2017.11.020. Epub 2017 Dec 8.

PMID:
29229176
47.

Radical Nephrectomy with or without Lymph Node Dissection for High Risk Nonmetastatic Renal Cell Carcinoma: A Multi-Institutional Analysis.

Gershman B, Thompson RH, Boorjian SA, Larcher A, Capitanio U, Montorsi F, Carenzi C, Bertini R, Briganti A, Lohse CM, Cheville JC, Leibovich BC.

J Urol. 2018 May;199(5):1143-1148. doi: 10.1016/j.juro.2017.11.114. Epub 2017 Dec 7.

PMID:
29225056
48.

Oncological and functional outcomes of elderly men treated with HIFU vs. minimally invasive radical prostatectomy: A propensity score analysis.

Capogrosso P, Barret E, Sanchez-Salas R, Nunes-Silva I, Rozet F, Galiano M, Ventimiglia E, Briganti A, Salonia A, Montorsi F, Cathelineau X.

Eur J Surg Oncol. 2018 Jan;44(1):185-191. doi: 10.1016/j.ejso.2017.11.008. Epub 2017 Dec 1.

PMID:
29223469
49.

Does Calculated Free Testosterone Overcome Total Testosterone in Protecting From Sexual Symptom Impairment? Findings of a Cross-Sectional Study.

Boeri L, Capogrosso P, Ventimiglia E, Cazzaniga W, Pederzoli F, Moretti D, Dehò F, Montanari E, Montorsi F, Salonia A.

J Sex Med. 2017 Dec;14(12):1549-1557. doi: 10.1016/j.jsxm.2017.10.070.

PMID:
29198510
50.

Long-term penile morphometric alterations in patients treated with robot-assisted versus open radical prostatectomy.

Capogrosso P, Ventimiglia E, Cazzaniga W, Stabile A, Pederzoli F, Boeri L, Gandaglia G, Dehò F, Briganti A, Montorsi F, Salonia A.

Andrology. 2018 Jan;6(1):136-141. doi: 10.1111/andr.12446. Epub 2017 Dec 1.

PMID:
29195014

Supplemental Content

Loading ...
Support Center